Cleveland Clinic is on the leading edge of healthcare transformation with accelerated digital technology and artificial intelligence integration.
The 23-hospital system has locations in multiple states and internationally, with 82,608 caregivers worldwide. The nearly $16 billion organization sees more than 3.4 million patients worldwide, including 1.1 million virtual visits. The health system is also focused on care advancement, with $520 million research funding and creating $1.4 billion in community impact.
But leadership is always looking ahead. To Conor Delaney, MD, PhD, CEO and president of Florida Region at Cleveland Clinic, the next billion-dollar question for healthcare executives is clear: How is AI transforming healthcare right now?
“At Cleveland Clinic, we’re actively implementing AI across our global health system to enhance clinical workflows, support our caregivers and ultimately improve patient experiences,” he said.
The health system launched a successful pilot of Ambience Healthcare’s AI scribe tool in and began deploying it systemwide in February.
“This is already proving to be a game-changer by reducing administrative burden, easing clinical burnout, and giving our providers more time to focus on what matters most: caring for patients,” he said. “With the continued use of AI, patient safety and transparency will remain at the core of our approach, and we’re only beginning.”
The health system is planning to launch a support tool for lower anterior resection syndrome, which will help patients with colorectal cancer manage their condition. The project is led by Marylise Boutros, MD, and aims to provide real-time education and support with Cleveland Clinic’s global database. The tool will generate AI-curated insights for patients to personally guide their healthcare journey.
“At Cleveland Clinic, every advancement with the help of AI is grounded in one goal: to make care more compassionate, connected and effective,” said Dr. Delaney. “We’re not just adopting the tool, rather we’re shaping its role in the future of medicine and redefining what’s possible.”
